[Cardiovascular effects of opioid receptor blocker naloxone].
Osadchiĭ
O E
OE
Normal Physiology Department, Kuban State Medical Academy, ul. Sedina 4, Krasnodar, 350640 Russia.
Pokrovskiĭ
V M
VM
D000889:Anti-Arrhythmia Agents / Q000494:pharmacology / Q000627:therapeutic use; D002317:Cardiovascular Agents / Q000494:pharmacology* / Q000627:therapeutic use; D006439:Hemodynamics / Q000187:drug effects; D006801:Humans; D009270:Naloxone / Q000494:pharmacology* / Q000627:therapeutic use; D009292:Narcotic Antagonists / Q000494:pharmacology* / Q000627:therapeutic use; D011957:Receptors, Opioid / Q000187:drug effects*
D000889:Anti-Arrhythmia Agents; D002317:Cardiovascular Agents; D009292:Narcotic Antagonists; D011957:Receptors, Opioid; D009270:Naloxone